These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 1902856)
21. IL-1 induces IL-1. III. Specific inhibition of IL-1 production by IFN-gamma. Ghezzi P; Dinarello CA J Immunol; 1988 Jun; 140(12):4238-44. PubMed ID: 3131429 [TBL] [Abstract][Full Text] [Related]
22. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor. Le JM; Vilcek J J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705 [TBL] [Abstract][Full Text] [Related]
23. Pre-exposure of human B cells to recombinant IL-1 enhances subsequent proliferation. Freedman AS; Freeman G; Whitman J; Segil J; Daley J; Nadler LM J Immunol; 1988 Nov; 141(10):3398-404. PubMed ID: 3141499 [TBL] [Abstract][Full Text] [Related]
25. Interleukin 13 suppresses cytokine production and stimulates the production of 15-HETE in PBMC. A comparison between IL-4 and IL-13. Deleuran B; Iversen L; Deleuran M; Yssel H; Kragballe K; Stengaard-Pedersen K; Thestrup-Pedersen K Cytokine; 1995 May; 7(4):319-24. PubMed ID: 8589261 [TBL] [Abstract][Full Text] [Related]
26. Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor. Paliogianni F; Ahuja SS; Balow JP; Balow JE; Boumpas DT J Immunol; 1993 Oct; 151(8):4081-9. PubMed ID: 8409387 [TBL] [Abstract][Full Text] [Related]
27. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids. Schleimer RP; Derse CP; Friedman B; Gillis S; Plaut M; Lichtenstein LM; MacGlashan DW J Immunol; 1989 Aug; 143(4):1310-7. PubMed ID: 2473127 [TBL] [Abstract][Full Text] [Related]
28. IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma. Pène J; Rousset F; Brière F; Chrétien I; Paliard X; Banchereau J; Spits H; De Vries JE J Immunol; 1988 Aug; 141(4):1218-24. PubMed ID: 3135324 [TBL] [Abstract][Full Text] [Related]
29. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients. Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of the inhibitory effects of budesonide on the mitogen-induced or the allergen-induced activation of blood mononuclear cells isolated from asthmatic patients. Oddera S; Silvestri M; Sacco O; Lantero S; Morelli MC; Rossi GA Ann Allergy Asthma Immunol; 1995 Jul; 75(1):33-40. PubMed ID: 7621058 [TBL] [Abstract][Full Text] [Related]
31. IL-4 expression in human T cells is selectively inhibited by IL-1 alpha and IL-1 beta. Sandborg CI; Imfeld KL; Zaldivar F; Wang Z; Buckingham BA; Berman MA J Immunol; 1995 Dec; 155(11):5206-12. PubMed ID: 7594531 [TBL] [Abstract][Full Text] [Related]
32. IL-2 and IL-12 act in synergy to overcome antigen-specific T cell unresponsiveness in mycobacterial disease. de Jong R; Janson AA; Faber WR; Naafs B; Ottenhoff TH J Immunol; 1997 Jul; 159(2):786-93. PubMed ID: 9218596 [TBL] [Abstract][Full Text] [Related]
33. Interferon-alpha inhibits proliferation in human T lymphocytes by abrogation of interleukin 2-induced changes in cell cycle-regulatory proteins. Erickson S; Sangfelt O; Castro J; Heyman M; Einhorn S; Grandér D Cell Growth Differ; 1999 Aug; 10(8):575-82. PubMed ID: 10470857 [TBL] [Abstract][Full Text] [Related]
34. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Mizuhara H; Uno M; Seki N; Yamashita M; Yamaoka M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H Hepatology; 1996 Jun; 23(6):1608-15. PubMed ID: 8675184 [TBL] [Abstract][Full Text] [Related]
35. Interferon-gamma overcomes the glucocorticoid-mediated and the interleukin-4-mediated inhibition of interleukin-1 beta synthesis in human monocytes. Geiger T; Arnold J; Rordorf C; Henn R; Vosbeck K Lymphokine Cytokine Res; 1993 Oct; 12(5):271-8. PubMed ID: 8260535 [TBL] [Abstract][Full Text] [Related]
36. IL-10 synergizes with dexamethasone in inhibiting human T cell proliferation. Brunetti M; Colasante A; Mascetra N; Piantelli M; Musiani P; Aiello FB J Pharmacol Exp Ther; 1998 May; 285(2):915-9. PubMed ID: 9580644 [TBL] [Abstract][Full Text] [Related]
37. T4 cell activation by immobilized phytohemagglutinin: differential capacity to induce IL-2 responsiveness and IL-2 production. Vine JB; Geppert TD; Lipsky PE J Immunol; 1988 Oct; 141(8):2593-600. PubMed ID: 2844904 [TBL] [Abstract][Full Text] [Related]
38. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. Kam JC; Szefler SJ; Surs W; Sher ER; Leung DY J Immunol; 1993 Oct; 151(7):3460-6. PubMed ID: 8376786 [TBL] [Abstract][Full Text] [Related]
40. Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation. Hernández-Caselles T; Stutman O J Immunol; 1993 Oct; 151(8):3999-4012. PubMed ID: 8409382 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]